Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Antibiotic misuse in respiratory tract infections in children and adults-a prospective, multicentre study (TAILORED Treatment).

van Houten CB, Cohen A, Engelhard D, Hays JP, Karlsson R, Moore E, Fernández D, Kreisberg R, Collins LV, de Waal W, de Winter-de Groot KM, Wolfs TFW, Meijers P, Luijk B, Oosterheert JJ, Heijligenberg R, Sankatsing SUC, Bossink AWJ, Stubbs A, Stein M, Reisfeld S, Klein A, Rachmilevitch R, Ashkar J, Braverman I, Kartun V, Chistyakov I, Bamberger E, Srugo I, Odeh M, Schiff E, Dotan Y, Boico O, Navon R, Friedman T, Etshtein L, Paz M, Gottlieb TM, Pri-Or E, Kronenfeld G, Simon E, Oved K, Eden E, Bont LJ.

Eur J Clin Microbiol Infect Dis. 2019 Mar;38(3):505-514. doi: 10.1007/s10096-018-03454-2. Epub 2019 Feb 1.

2.

Borderline QuantiFERON results and the distinction between specific responses and test variability.

Uzorka JW, Bossink AWJ, Franken WPJ, Thijsen SFT, Leyten EMS, van Haeften AC, Doornenbal G, Boonstra P, Ottenhoff THM, Arend SM.

Tuberculosis (Edinb). 2018 Jul;111:102-108. doi: 10.1016/j.tube.2018.06.002. Epub 2018 Jun 7.

3.

An Enzyme-Linked Immunosorbent Spot Assay Measuring Borrelia burgdorferi B31-Specific Interferon Gamma-Secreting T Cells Cannot Discriminate Active Lyme Neuroborreliosis from Past Lyme Borreliosis: a Prospective Study in the Netherlands.

van Gorkom T, Sankatsing SUC, Voet W, Ismail DM, Muilwijk RH, Salomons M, Vlaminckx BJM, Bossink AWJ, Notermans DW, Bouwman JJM, Kremer K, Thijsen SFT.

J Clin Microbiol. 2018 Mar 26;56(4). pii: e01695-17. doi: 10.1128/JCM.01695-17. Print 2018 Apr.

4.

QuantiFERON-plus does not discriminate between active and latent tuberculosis.

Hofland RW, Bossink AWJ, Nierkens S, Paardekooper SPA, van den Broek BTA, Lammers JJ, van Haeften I, Thijsen SFT.

Infect Dis (Lond). 2018 Jun;50(6):479-482. doi: 10.1080/23744235.2018.1425550. Epub 2018 Jan 15. No abstract available.

PMID:
29334817
5.

Positive predictive value of ELISpot in BAL and pleural fluid from patients with suspected pulmonary tuberculosis.

Hofland RW, Thijsen SF, van Lindert AS, de Lange WC, van Gorkom T, van der Tweel I, Lammers JJ, Bossink AW.

Infect Dis (Lond). 2017 May;49(5):347-355. doi: 10.1080/23744235.2016.1269190. Epub 2016 Dec 26.

PMID:
28024452
6.

Pleural Fluid and Tuberculosis: Are All Interferon Gamma Release Assays Equal?

Hofland RW, Bossink AW, Lammers JW, Thijsen SF.

J Clin Microbiol. 2016 Feb;54(2):504-5. doi: 10.1128/JCM.02653-15. No abstract available.

7.

False-negative interferon-γ release assay results in active tuberculosis: a TBNET study.

de Visser V, Sotgiu G, Lange C, Aabye MG, Bakker M, Bartalesi F, Brat K, Chee CB, Dheda K, Dominguez J, Eyuboglu F, Ghanem M, Goletti D, Dilektasli AG, Guglielmetti L, Koh WJ, Latorre I, Losi M, Polanova M, Ravn P, Ringshausen FC, Rumetshofer R, de Souza-Galvão ML, Thijsen S, Bothamley G, Bossink A; TBNET.

Eur Respir J. 2015 Jan;45(1):279-83. doi: 10.1183/09031936.00120214. Epub 2014 Oct 30. No abstract available.

8.

Sarcoidosis and Purified Protein Derivative reactivity.

Hofland RW, Thijsen SF, Bouwman J, van der Wel M, Bossink AW.

Sarcoidosis Vasc Diffuse Lung Dis. 2014 Jul 8;31(2):142-8.

PMID:
25078642
9.

Tuberculosis during TNF-α inhibitor therapy, despite screening.

Hofland RW, Thijsen SF, Verhagen MA, Schenk Y, Bossink AW.

Thorax. 2013 Nov;68(11):1079-80. doi: 10.1136/thoraxjnl-2012-202974. Epub 2013 Apr 18.

PMID:
23598710
10.

Unilateral tongue atrophy and pulmonary malignancy.

Schulkes KJ, Bossink AW.

Neth J Med. 2013 Jan;71(1):32-5. No abstract available.

11.

Added value of use of a purified protein derivative-based enzyme-linked immunosorbent spot assay for patients with Mycobacterium bovis BCG infection after intravesical BCG instillations.

Heemstra KA, Bossink AW, Spermon R, Bouwman JJ, van der Kieft R, Thijsen SF.

Clin Vaccine Immunol. 2012 Jun;19(6):974-7. doi: 10.1128/CVI.05597-11. Epub 2012 Mar 29.

12.

Improving the timeframe between blood collection and interferon gamma release assay using T-Cell Xtend®.

Bouwman JJ, Thijsen SF, Bossink AW.

J Infect. 2012 Feb;64(2):197-203. doi: 10.1016/j.jinf.2011.10.017. Epub 2011 Nov 18.

PMID:
22120115
13.

Developing a new clinical tool for diagnosing chronic Q fever: the Coxiella ELISPOT.

Limonard GJ, Thijsen SF, Bossink AW, Asscheman A, Bouwman JJ.

FEMS Immunol Med Microbiol. 2012 Feb;64(1):57-60. doi: 10.1111/j.1574-695X.2011.00890.x. Epub 2011 Nov 21.

14.

Tuberculosis-specific T-cell response after recent treatment and remote cure.

van Gemert JP, Thijsen SF, Bossink AW.

Eur Respir J. 2011 Nov;38(5):1225-8. doi: 10.1183/09031936.00170010. No abstract available.

15.

Diagnostic potential of an enzyme-linked immunospot assay in tuberculous pericarditis.

Bathoorn E, Limburg A, Bouwman JJ, Bossink AW, Thijsen SF.

Clin Vaccine Immunol. 2011 May;18(5):874-7. doi: 10.1128/CVI.00031-11. Epub 2011 Mar 30.

16.

Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis.

Sester M, Sotgiu G, Lange C, Giehl C, Girardi E, Migliori GB, Bossink A, Dheda K, Diel R, Dominguez J, Lipman M, Nemeth J, Ravn P, Winkler S, Huitric E, Sandgren A, Manissero D.

Eur Respir J. 2011 Jan;37(1):100-11. doi: 10.1183/09031936.00114810. Epub 2010 Sep 16. Review. Erratum in: Eur Respir J. 2012 Mar;39(3):793.

17.

Bronchoalveolar lavage immunodiagnosis for tuberculosis suspects in Europe and Africa.

Lange C, Bossink A, Eberhardt R, Goletti D, Jafari C, Latorre I, Kirsten D, Losi M, Migliori GB, Sotgiu G.

Thorax. 2010 Sep;65(9):842; author reply 842-3. doi: 10.1136/thx.2009.124958. No abstract available.

PMID:
20805186
18.

The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement.

Solovic I, Sester M, Gomez-Reino JJ, Rieder HL, Ehlers S, Milburn HJ, Kampmann B, Hellmich B, Groves R, Schreiber S, Wallis RS, Sotgiu G, Schölvinck EH, Goletti D, Zellweger JP, Diel R, Carmona L, Bartalesi F, Ravn P, Bossink A, Duarte R, Erkens C, Clark J, Migliori GB, Lange C.

Eur Respir J. 2010 Nov;36(5):1185-206. doi: 10.1183/09031936.00028510. Epub 2010 Jun 7.

19.

Bronchoalveolar lavage enzyme-linked immunospot for a rapid diagnosis of tuberculosis: a Tuberculosis Network European Trialsgroup study.

Jafari C, Thijsen S, Sotgiu G, Goletti D, Domínguez Benítez JA, Losi M, Eberhardt R, Kirsten D, Kalsdorf B, Bossink A, Latorre I, Migliori GB, Strassburg A, Winteroll S, Greinert U, Richeldi L, Ernst M, Lange C; Tuberculosis Network European Trialsgroup.

Am J Respir Crit Care Med. 2009 Oct 1;180(7):666-73. doi: 10.1164/rccm.200904-0557OC. Epub 2009 Jul 9.

20.

LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement.

Mack U, Migliori GB, Sester M, Rieder HL, Ehlers S, Goletti D, Bossink A, Magdorf K, Hölscher C, Kampmann B, Arend SM, Detjen A, Bothamley G, Zellweger JP, Milburn H, Diel R, Ravn P, Cobelens F, Cardona PJ, Kan B, Solovic I, Duarte R, Cirillo DM; C. Lange; TBNET.

Eur Respir J. 2009 May;33(5):956-73. doi: 10.1183/09031936.00120908.

21.

Interferon gamma release assays for diagnosing active and latent tuberculosis.

Thijsen SF, Bossink AW.

Expert Opin Med Diagn. 2009 May;3(3):303-12. doi: 10.1517/17530050902758738. Epub 2009 Apr 8.

PMID:
23488465
22.

The value of interferon gamma release assays for diagnosis infection with Mycobacterium tuberculosis during an annual screening of health care workers.

Thijsen SF, van Rossum SV, Arend S, Koster B, Machiels AM, Bossink AW.

J Occup Environ Med. 2008 Nov;50(11):1207-8. doi: 10.1097/JOM.0b013e31818def3d. No abstract available.

PMID:
19001946
23.

A possible role for Epstein-Barr virus infection in COPD?

Bossink AW, Deege M, Thijsen SF.

Eur Respir J. 2008 Nov;32(5):1411-2; author reply 1413. doi: 10.1183/09031936.00096308. No abstract available.

24.

Interferon-gamma release assays during follow-up of tuberculin skin test-positive contacts.

Franken WP, Arend SM, Thijsen SF, Bouwman JJ, Koster BF, van Dissel JT, Bossink AW.

Int J Tuberc Lung Dis. 2008 Nov;12(11):1286-94.

PMID:
18926039
25.

Rapid diagnosis of CNS tuberculosis by a T-cell interferon-gamma release assay on cerebrospinal fluid mononuclear cells.

Kösters K, Nau R, Bossink A, Greiffendorf I, Jentsch M, Ernst M, Thijsen S, Hinks T, Lalvani A, Lange C.

Infection. 2008 Dec;36(6):597-600. doi: 10.1007/s15010-007-7316-0. Epub 2008 Jan 12.

PMID:
18193383
26.

A 65-year-old male patient with hoarseness of voice.

Bijlsma-van Leeuwen RM, Bossink AW.

Neth J Med. 2007 Sep;65(8):307-8; quiz 308. No abstract available.

27.

Use of a T-cell interferon-gamma release assay for the diagnosis of tuberculous pleurisy.

Losi M, Bossink A, Codecasa L, Jafari C, Ernst M, Thijsen S, Cirillo D, Ferrarese M, Greinert U, Fabbri LM, Richeldi L, Lange C; European Tuberculosis Network TBNET.

Eur Respir J. 2007 Dec;30(6):1173-9. Epub 2007 Aug 22.

28.

Follow-up study of tuberculosis-exposed supermarket customers with negative tuberculin skin test results in association with positive gamma interferon release assay results.

Franken WP, Koster BF, Bossink AW, Thijsen SF, Bouwman JJ, van Dissel JT, Arend SM.

Clin Vaccine Immunol. 2007 Sep;14(9):1239-41. Epub 2007 Jul 11.

29.

Exclusion of active Mycobacterium tuberculosis complex infection with the T-SPOT.TB assay.

van Leeuwen RM, Bossink AW, Thijsen SF.

Eur Respir J. 2007 Mar;29(3):605-7. Erratum in: Eur Respir J. 2007 Jun;29(6):1286.

30.

Effect of tuberculin skin testing on a Mycobacterium tuberculosis-specific interferon-gamma assay.

Leyten EM, Prins C, Bossink AW, Thijsen S, Ottenhoff TH, van Dissel JT, Arend SM.

Eur Respir J. 2007 Jun;29(6):1212-6. Epub 2007 Jan 10.

31.

Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts.

Arend SM, Thijsen SF, Leyten EM, Bouwman JJ, Franken WP, Koster BF, Cobelens FG, van Houte AJ, Bossink AW.

Am J Respir Crit Care Med. 2007 Mar 15;175(6):618-27. Epub 2006 Dec 14.

PMID:
17170386
32.

Empyema in a patient treated with infliximab: it is not what it seems.

Bossink A, Thijsen S, van Houte AJ.

Ann Rheum Dis. 2005 Nov;64(11):1657-8. No abstract available.

33.

A possible role for Epstein-Barr virus in the pathogenesis of pleural effusion.

Thijsen SF, Luderer R, van Gorp JM, Oudejans SJ, Bossink AW.

Eur Respir J. 2005 Oct;26(4):662-6.

34.

[A patient with Legionella pneumophila serogroup-3 pneumonia, detected by PCR].

Herpers BL, Bossink AW, Cohen Stuart JW, Hustinx WN, Thijsen SF.

Ned Tijdschr Geneeskd. 2005 Sep 3;149(36):2009-12. Dutch.

PMID:
16171114
35.

Circulating inflammatory mediators predict shock and mortality in febrile patients with microbial infection.

Groeneveld AB, Tacx AN, Bossink AW, van Mierlo GJ, Hack CE.

Clin Immunol. 2003 Feb;106(2):106-15.

PMID:
12672401
36.

Circulating inflammatory mediators in patients with fever: predicting bloodstream infection.

Groeneveld AB, Bossink AW, van Mierlo GJ, Hack CE.

Clin Diagn Lab Immunol. 2001 Nov;8(6):1189-95.

37.

Early inhibition of activated fibrinolysis predicts microbial infection, shock and mortality in febrile medical patients.

Raaphorst J, Johan Groeneveld AB, Bossink AW, Erik Hack C.

Thromb Haemost. 2001 Aug;86(2):543-9.

PMID:
11522001
38.

Prediction of shock in febrile medical patients with a clinical infection.

Bossink AW, Groeneveld AB, Koffeman GI, Becker A.

Crit Care Med. 2001 Jan;29(1):25-31.

PMID:
11176153
39.
41.

The clinical host response to microbial infection in medical patients with fever.

Bossink AW, Groeneveld AB, Hack CE, Thijs LG.

Chest. 1999 Aug;116(2):380-90.

PMID:
10453866
42.
43.

Complement activation in patients with sepsis is in part mediated by C-reactive protein.

Wolbink GJ, Bossink AW, Groeneveld AB, de Groot MC, Thijs LG, Hack CE.

J Infect Dis. 1998 Jan;177(1):81-7.

PMID:
9419173
44.

Plasma levels of the chemokines monocyte chemotactic proteins-1 and -2 are elevated in human sepsis.

Bossink AW, Paemen L, Jansen PM, Hack CE, Thijs LG, Van Damme J.

Blood. 1995 Nov 15;86(10):3841-7.

PMID:
7579352

Supplemental Content

Loading ...
Support Center